<!doctype html>

<html lang="zh-CN">
	<head>
		<meta charset="utf-8" />
		<meta name="viewport" content="width=device-width,initial-scale=1" />

		<link rel="icon" type="image/png" sizes="32x32" href="/favicon.png" />
		<link rel="icon" type="image/png" sizes="16x16" href="/favicon@16x16.png" />

		<link rel="alternate" type="application/rss+xml" title="RSS" href="/rss.xml" />

		<script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@4/tex-mml-chtml.js"></script>

		<title>
			
秋槭与石桥都消失不见 - Stahl&#x27;s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications 笔记目录

		</title>

		<link rel="stylesheet" href="/font.css" />
		<link rel="stylesheet" href="/base.css" />
		
<link rel="stylesheet" href="/page.css" />

	</head>

	<body>
		
<nav>
    <ul>
        <li>
            <a href="/">home</a>
        </li>
        <li>
            <a href="/blog/">blog</a>
        </li>
        <li>
            <a>图片库</a>
        </li>
        <li>
            <a>关于本站</a>
        </li>
    </ul>
</nav>

<section>
    <h1>
        Stahl&#x27;s Essential Psychopharmacology: Neuroscientific Basis and Practical Applications 笔记目录
    </h1>
</section>

<section>
    <p>
        
    </p>
</section>



<section class="bordered">
    <ul>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1">1 Chemical Neurotransmission 化学神经传导</a>
<ul>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1/#1-1-anatomical-versus-chemical-basis-of-neurotransmission-shen-jing-chuan-dao-de-ji-chu-cong-jie-pou-xue-dao-hua-xue">1.1 Anatomical versus Chemical Basis of Neurotransmission 神经传导的基础：从解剖学到化学</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1/#1-2-principles-of-chemical-neurotransmission-hua-xue-shen-jing-chuan-dao-de-yuan-li">1.2 Principles of Chemical Neurotransmission 化学神经传导的原理</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1/#1-3-signal-transduction-cascades-xin-hao-zhuan-dao">1.3 Signal Transduction Cascades 信号转导</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1/#1-4-epigenetics-biao-guan-yi-chuan">1.4 Epigenetics 表观遗传</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-1/#1-5-a-brief-word-about-rna-rnajian-jie">1.5 A Brief Word about RNA RNA简介</a></li>
</ul>
</li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-2">2 Transporters, Receptors, and Enzymes as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的转运体、受体和酶</a>
<ul>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-2/#2-1-neurotransmitter-transporters-as-targets-of-drug-action-zuo-wei-yao-ba-dian-de-di-zhi-zhuan-yun-ti">2.1 Neurotransmitter Transporters as Targets of Drug Action 作为药靶点的递质转运体</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-2/#2-2-g-protein-linked-receptors-gdan-bai-ou-lian-shou-ti">2.2 G-Protein-Linked Receptors G蛋白耦联受体</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-2/#2-3-enzymes-as-sites-of-psychopharmacological-drug-action-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian-de-mei">2.3 Enzymes as Sites of Psychopharmacological Drug Action 作为精神药理学药靶点的酶</a></li>
<li><a href="/blog/20250919-psychopharmacology-note-chapter-2/#2-4-cytochrome-p450-drug-metabolizing-enzymes-as-targets-of-psychotropic-drugs-zuo-wei-jing-shen-yao-ba-dian-de-yao-dai-xie-mei-cyp450">2.4 Cytochrome P450 Drug Metabolizing Enzymes as Targets of Psychotropic Drugs 作为精神药靶点的药代谢酶CYP450</a></li>
</ul>
</li>
<li><a href="/blog/20251021-psychopharmacology-note-chapter-3/">3 Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的离子通道</a>
<ul>
<li><a href="/20251021-psychopharmacology-note-chapter-3/#3-1-ligand-gated-ion-channels-as-targets-of-psychopharmacological-drug-action-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian-de-pei-ti-men-kong-chi-zi-tong-dao">3.1 Ligand-Gated Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的配体门控离子通道</a></li>
<li><a href="/blog/20251021-psychopharmacology-note-chapter-3/#3-2-voltage-sensitive-ion-channels-as-targets-of-psychopharmacological-drug-action-zuo-wei-jing-shen-yao-li-xue-yao-ba-dian-de-dian-min-chi-zi-tong-dao">3.2 Voltage-Sensitive Ion Channels as Targets of Psychopharmacological Drug Action 作为精神药理学药靶点的电敏离子通道</a></li>
<li><a href="/blog/20251021-psychopharmacology-note-chapter-3/#3-3-ion-channels-and-neurotransmission-chi-zi-tong-dao-he-shen-jing-chuan-shu">3.3 Ion Channels and Neurotransmission 离子通道和神经传输</a></li>
</ul>
</li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/">4 Psychosis, Schizophrenia, and the Neurotransmitter Networks Dopamine, Serotonin, and Glutamate 精神病性症状、精神分裂症以及多巴胺、5-HT和谷氨酸的神经递质网络</a>
<ul>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-1-symptoms-of-psychosis-jing-shen-bing-xing-zheng-zhuang">4.1 Symptoms of Psychosis 精神病性症状</a></li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-2-the-three-major-hypotheses-of-psychosis-and-their-neurotransmitter-networks-jing-shen-bing-xing-zheng-zhuang-de-3zhu-yao-jia-shuo-ji-qi-shen-jing-di-zhi-wang-luo">4.2 The Three Major Hypotheses of Psychosis and Their Neurotransmitter Networks 精神病性症状的3主要假说及其神经递质网络</a></li>
<li><a href="https://maple-and-stonebridge.github.io/blog/20250919-psychopharmacology-note-index/=/blog/20251106-psychopharmacology-note-chapter-4/#4-3-the-classic-dopamine-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-jing-dian-duo-ba-e-jia-shuo">4.3 The Classic Dopamine Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的经典多巴胺假说</a></li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-4-the-glutamate-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-gu-an-suan-jia-shuo">4.4 The Glutamate Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的谷氨酸假说</a></li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-5-the-serotonin-hypothesis-of-psychosis-and-schizophrenia-jing-shen-bing-xing-zheng-zhuang-he-jing-shen-fen-lie-zheng-de-5-htjia-shuo">4.5 The Serotonin Hypothesis of Psychosis and Schizophrenia 精神病性症状和精神分裂症的5-HT假说</a></li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-6-schizophrenia-as-the-prototypical-psychotic-disorder-jing-shen-fen-lie-zheng-zuo-wei-dian-xing-jing-shen-bing-xing-zhang-ai">4.6 Schizophrenia as the Prototypical Psychotic Disorder 精神分裂症作为典型精神病性障碍</a></li>
<li><a href="/blog/20251106-psychopharmacology-note-chapter-4/#4-7-other-psychotic-illnesses-qi-ta-jing-shen-bing-xing-zhang-ai">4.7 Other Psychotic Illnesses 其他精神病性障碍</a></li>
</ul>
</li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/">5 Targeting Dopamine and Serotonin Receptors for Psychosis, Mood, and Beyond: So-Called "Antipsychotics" 作用于多巴胺和5-HT受体治疗精神病性症状和心境症状等的“抗精神病药”</a>
<ul>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-1-targeting-mesolimbic-mesostriatal-dopamine-d2-receptors-causes-antipsychotic-actions-zuo-yong-yu-zhong-nao-bian-yuan-zhong-nao-wen-zhuang-ti-d2shou-ti-zao-cheng-kang-jing-shen-bing-xiao-ying">5.1 Targeting Mesolimbic/Mesostriatal Dopamine D2 Receptors Causes Antipsychotic Actions 作用于中脑边缘/中脑纹状体D2受体造成抗精神病效应</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-2-targeting-dopamine-d2-receptors-in-mesolimbic-mesostriatal-and-mesocortical-pathways-causes-secondary-negative-symptoms-zuo-yong-yu-zhong-nao-bian-yuan-zhong-nao-wen-zhuang-ti-he-zhong-nao-pi-zhi-d2shou-ti-zao-cheng-ji-fa-xing-yin-xing-zheng-zhuang">5.2 Targeting Dopamine D2 Receptors in Mesolimbic/Mesostriatal and Mesocortical Pathways Causes Secondary Negative Symptoms 作用于中脑边缘/中脑纹状体和中脑皮质D2受体造成继发性阴性症状</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-3-targeting-tuberoinfundibular-dopamine-d2-receptors-causes-elevation-of-prolactin-zuo-yong-yu-jie-jie-lou-dou-d2shou-ti-zao-cheng-cui-ru-su-sheng-gao">5.3 Targeting Tuberoinfundibular Dopamine D2 Receptors Causes Elevation of Prolactin 作用于结节漏斗D2受体造成催乳素升高</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-4-targeting-nigrostriatal-dopamine-d2-receptors-causes-motor-side-effects-zuo-yong-yu-hei-zhi-wen-zhuang-ti-d2shou-ti-zao-cheng-yun-dong-fu-xiao-ying">5.4 Targeting Nigrostriatal Dopamine D2 Receptors Causes Motor Side Effects 作用于黑质纹状体D2受体造成运动副效应</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-5-drugs-targeting-dopamine-d2-receptors-so-called-first-generation-or-conventional-antipsychotics-zuo-yong-yu-d2shou-ti-de-di-yi-dai-dian-xing-kang-jing-shen-bing-yao">5.5 Drugs Targeting Dopamine D2 Receptors: So-Called First Generation or Conventional "Antipsychotics" 作用于D2受体的“第一代/典型抗精神病药”</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-6-drugs-targeting-serotonin-2a-receptors-with-or-without-simultaneously-targeting-dopamine-d2-receptors-zuo-yong-yu-5ht2ashou-ti-he-fei-zuo-yong-yu-d2shou-ti-de-yao">5.6 Drugs Targeting Serotonin 2A Receptors with or without Simultaneously Targeting Dopamine D2 Receptors 作用于5HT2A受体和/非作用于D2受体的药</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-7-drugs-targeting-serotonin-1a-receptors-and-dopamine-d2-receptors-as-partial-agonists-5ht1a-d2bu-fen-ji-dong-yao">5.7 Drugs Targeting Serotonin 1A Receptors and Dopamine D2 Receptors as Partial Agonists 5HT1A/D2部分激动药</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-8-links-between-receptor-binding-properties-of-drugs-used-to-treat-psychosis-and-other-therapeutic-actions-and-side-effects-shou-ti-he-xiao-ying-de-guan-lian">5.8 Links between Receptor Binding Properties of Drugs Used to Treat Psychosis and Other Therapeutic Actions and Side Effects 受体和效应的关联</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-9-pharmacological-properties-of-selected-individual-first-generation-d2-antagonists-bu-fen-d2zu-zhi-yao-de-yao-li-xue-xing-zhi">5.9 Pharmacological Properties of Selected Individual First-Generation D2 Antagonists 部分D2阻滞药的药理学性质</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-10-an-overview-of-the-pharmacological-properties-of-individual-5ht2a-d2-antagonists-and-d2-5ht1a-partial-agonists-the-pines-peens-many-dones-and-a-rone-two-pips-and-a-rip-ge-d2-5ht2azu-zhi-yao-he-d2-5ht1abu-fen-ji-dong-yao-de-yao-li-xue-xing-zhi-gai-shu">5.10 An Overview of the Pharmacological Properties of Individual 5HT2A/D2 Antagonists and D2/5HT1A Partial Agonists: The Pines (Peens), Many Dones and a Rone, Two Pips and a Rip 各D2/5HT2A阻滞药和D2/5HT1A部分激动药的药理学性质概述</a></li>
<li><a href="/blog/20251219-psychopharmacology-note-chapter-5/#5-11-future-treatments-for-schizophrenia-jing-shen-fen-lie-zheng-zhi-liao-zhan-wang">5.11 Future Treatments for Schizophrenia 精神分裂症治疗展望</a></li>
</ul>
</li>
<li>6 Mood Disorders and the Neurotransmitter Networks Norepinephrine and γ-Aminobutyric Acid (GABA) 心境障碍以及去甲肾上腺素和GABA的神经递质网络</li>
<li>7 Treatment for Mood Disorders: So-Called "Antidepressants" and "Mood Stabilizers" 治疗心境障碍的“抗抑郁药”和“心境稳定药”</li>
<li>8 Anxiety, Trauma, and Treatment 焦虑和创伤及其治疗</li>
<li>9 Chronic Pain and Its Treatment 慢性疼痛及其治疗</li>
<li>10 Disorders of Sleep and Wakefulness and Their Treatment: Neurotransmitter Networks for Histamin and Orexin 睡眠觉醒障碍、其治疗以及组胺和食欲素的神经递质网络</li>
<li>11 Attention Deficit Hyperactivity Disorder and Its Treatment 注意缺陷多动障碍及其治疗</li>
<li>12 Dementia: Causes, Symptomatic Treatments, and the Neurotransmitter Network Acetylcholine 痴呆的病因、对症治疗以及乙酰胆碱的神经递质网络</li>
<li>13 Impulsivity, Compulsivity, and Addiction 冲动、强迫和成瘾</li>
</ul>

</section>

<section>
    2025-09-19
</section>

<section>
    
        # <a href="https://maple-and-stonebridge.github.io/category/bi-ji/"> 笔记 </a>
    
    
        
            # <a href="https://maple-and-stonebridge.github.io/field/yi-xue/"> 医学 </a>
        
            # <a href="https://maple-and-stonebridge.github.io/field/yao-li-xue/"> 药理学 </a>
        
            # <a href="https://maple-and-stonebridge.github.io/field/jing-shen-yao-li-xue/"> 精神药理学 </a>
        
    
    
</section>


		<footer>
			<p>除非另有说明，本站所有本人创作内容均通过CC0协议释放至公共领域～ Unless other specified, all content by me is released into public domain under CC0 license~~<br /> chsungyesuzuki 2025 no rights reserved</p>
			<a rel="license" href="https://creativecommons.org/publicdomain/zero/1.0/legalcode"><img src="/cc0.png" alt="CC0 Legal Code" /></a>
			<a href="/rss.xml"> <img src="/rss-icon.png" alt="RSS" /> </a>
		</footer>
	</body>
</html>

